COVID-19 has impacted our lives in many ways, including healthcare. During this webinar you’ll gain an understanding of patients’ experiences of health care at a distance and how telehealth will impact pharma strategies. Our discussion focused on how COVID-19 affected patients’ interactions with HCPs, patients’ perceptions of the quality of care via telehealth and the differences in experiences and perceptions between countries.



Janneke van den Bent


Bill Salokar
VP Client Solutions

Topics we covered:

  • Initial patients’ experiences of the transition to care at a distance proved to be positive, however, it’s important to realize that this may not be a lasting impression.
  • Setting patients at the heart of redefining strategies becomes a must. Patient centricity takes a new dimension in digital care/care at a distance.
  • Empowering patients to play a relevant role in the decision-making process is more imperative than ever, especially now that the right treatment is based on a patient’s ability to communicate their physical and mental health, via a web-based video conferencing platform.